From the desk of Doctor James Rybacki
Breaking News for Melanoma and potentially other oncology patients
The Medicine Information Institute
Dr. James Joseph Rybacki | 6300 North Wickham Road. Suite 189 o Melbourne, Fla 32940 | Ph. 410.310.2578 o Fax 321.241.4343
Breaking medicine approval for www.EssentialGuideToPrescriptionDrugs.com
Breaking News for Melanoma and potentially other oncology patients
I was surprised this morning and a major change has come to help Melanoma and potentially other oncology patients.
BREAKTHROUGH Medicine FDA approved 9/11/23
Aphexdra (motixafortide) has been approved by the FDA and is the FIRST innovation in ten years for multiple myeloma patients. This novel medicine is to be used in combination with Filgrastim (G-CSF) to mobilize crucial Stem Cells for collection and Subsequent patient transplant (Autologous) in people with Multiple Myeloma.
Multiple myeloma (MM) is a cancer of the blood that does NOT have a cure. This incurable cancer affects a crucial kind of white blood cell called a plasma cell in the bone marrow. In MM patients, these abnormal plasma cells spread and replace normal cells and this diagnosis happens in more than 35,000 in the US. Nearly 13,000 patients die from MM each year (Click here to read more).
Continuation to be placed on a new landing page/article for Channel 2, the Leading Edge of Medicines and Guidelines.
…Aphexdra (motixafortide) is expected to become the new standard of care in myeloma patients who are going to get a bone marrow transplant (Autologous Stem Cell Therapy or ASCT). It will be used in combination with an older medicine called filgrastim (G-CSF) to help make certain that the required number of cells can be mobilized (3-5 X 106 CD34+ cells/kg2) to be successful.
Remarkably, this medicine is expected to actually be available to help patients in late September 2023. The company plans a conference call September 12, 2023 and already has a video press release detailing the medicine further at www.Biolinerx.com
More to follow as always on this True Breakthrough with a detailed video on Channel Two of this site by September 21, 2023.
Thanks for reading the Breaking News for Melanoma and potentially other oncology patients
“Dr. Jim” Doctor James Rybacki, Pharm.D.
President, The Medicine Information Institute / Author, The Essential Guide to Prescription Drugs, Medicines and Your Family & Author, The Essential Guide to Prescription Drugs, Update on Aspirin / Editor, Doctorjimrybacki.com; & www.EssentialGuideToPrescriptionDrugs.com [essentialguidetoprescriptiondrugs.com]
Amazon author central: https://www.amazon.com/author/jamesrybacki [amazon.com]
